Ted Pellas

Head, Oncology Imaging - Oncology Clinical Development at GSK

Role
Ed, Head of Oncology Imaging, Oncology Clinical Development at GSK
Location
New Providence, NJ, US
LinkedIn followers
500 followers

About Ted Pellas

Exec. Dir, Imaging Lead, Oncology Clinical Development GSK R&D with extensive preclinical, translational, early, and late phase clinical imaging experience in biopharmaceutical drug development. Specialty areas include Immuno-Oncology, Oncology, Immunology, and Musculoskeletal Imaging. Proficient at leading clinical imaging strategy and execution in Oncology & IO clinical trials (immune checkpoint inhibitors/agonists, targeted therapy, cell imaging, synthetic lethality, ADCs, combination trials), with cross-portfolio standardization & harmonization (via templates, smart EDC, SDTM/CDISC output, etc.). Subject matter expert in tumor assessment criteria. Experienced in quantitative molecular PET imaging probe development using large molecule vectors (antibodies, mAb fragments, etc.) in pre-clinical development, including applications for cell imaging, T cell effector imaging, tumor imaging, etc.AREAS OF EXPERTISE & COLLABORATIONImmuno-Oncology/Oncology Clinical Research | Biologics, Antibodies, ADCs, Small Molecules | GxP, ICH; CRF, ICF | Clinical Study Protocols / Templates | Imaging CROs, Imaging Charters, DTS | CMC Biologics Manufacturing | Ad Boards, Steering Committees, Site Initiations | Budget, Portfolio & basic Project Management | Tumor Immunology, Cancer Immunotherapy: CTLA-4, PD-1, PD-L1, Nivolumab, Ipilimumab, Durvalumab, Tremelimumab, Dostarlimab; Targeted therapy: mTOR, Brivanib, IGF-1R, Jak2, CXCR4, Smoothened, Notch, Imatinib, Deferasirox | Autoimmunity (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis): Abatacept, Clazakizumab, Canakinumab, Secukinumab | Data Visualization, Spotfire | Molecular Imaging: PET/MRI/CT/DEXA/Optical | Pharmacology; PK/PD | Mesenchymal Stem Cell tissue regeneration | Structural Biology, Molecular Pathology• Demonstrated matrix accountability and leadership skills as an Imaging SMEmisspellings Theadore Pelas Pellis Pallas

Experience

  1. Ed, Head of Oncology Imaging, Oncology Clinical Development

    GSK

    Sep 2025 — Present

Education

  • University of Pennsylvania

    VMD (DVM), School of Veterinary Medicine

  • Penn State University

    Bachelor's Degree, Animal Science

  • University of Pennsylvania

    PhD, Experimental Pathology/Immunology

  • Penn State University

    Master's Degree, Animal Physiology

Skills

  • Inflammation
  • Cell Biology
  • Biotechnology
  • Stem Cells
  • Antibodies
  • Clinical Trials
  • Regulatory Affairs
  • Lifesciences
  • Immunology
  • Clinical Development
  • Regulatory Submissions
  • In Vivo
  • Molecular Biology
  • Clinical Study Design
  • Therapeutic Areas
  • Pharmacology
  • Medical Writing
  • Immuno-Oncology
  • Cell
  • Life Sciences
  • Clinical Research
  • Clinical Pharmacology
  • Imaging
  • Pharmaceutical Industry
  • Drug Discovery
  • Biomarkers
  • Autoimmune Diseases
  • In Vitro
  • Medical Imaging
  • Molecular Imaging
  • Medicine
  • Digital Imaging
  • Oncology
  • Protocol
  • Infectious Diseases
  • Immunohistochemistry
  • Glp
  • Translational Medicine
  • CRO
  • Commercialization

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ted Pellas — Ed, Head of Oncology Imaging, Oncology Clinical Development at GSK in New Providence, NJ, US | Unifers